Bibliografia

1 - Mandal A, Mayberry J. (2003). Frequently asked questions about inflammatory bowel disease. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp743–755). Edinburgh: Churchill Livingstone Elsevier.
2 - Travis S, Jewel DP. (2003). Ulcerative colitis: clinical presentation and diagnosis. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp169–181). Edinburgh: Churchill Livingstone Elsevier.
3 - Pallone F, Monteleone G, Montelone I, Biancone L. (2003). The immune system in inflammatory bowel disease. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp85–93). Edinburgh: Churchill Livingstone Elsevier.
4 - Panès J Sans M, Piquè JM. (2003). Cell adhesion molecules. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp121–131). Edinburgh: Churchill Livingstone Elsevier.
5 - Marshall JK, Hilsden RJ. (2003). Environment and epidemiology of inflammatory bowel disease. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp17–28). Edinburgh: Churchill Livingstone Elsevier.
6 - Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scand J Gastroenterol 1996;31:892–9.
7 - Manuale di Gastroenterologia UNIGASTRO Edizione 2004-2006 pagg 439-440
8 - Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999;28(2):255–81, vii.
9 - Orchard TR. (2003). Extraintestinal manifestations: skin, joints and mucocutaneous manifestations. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp669–684). Edinburgh: Churchill Livingstone Elsevier.
10 - Satsangi J. (2003). Chapter 6. Overview. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp585–587). Edinburgh: Churchill Livingstone Elsevier.
11 - Ullman TA, Itzkowitz SH. (2003). Cancer risk in inflammatory bowel disease. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp605–619). Edinburgh: Churchill Livingstone Elsevier.
12 - Dott. Paolo Gionchetti, IBD Research Hospital, University of Bologna, www.amiciitalia.org. Accessed 23 March 2009.
13 - Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107(1):3–11.
14 - Ng SC, Kamm MA. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis. 2008 Nov 4. [Epub ahead of print].
15 - Crohn's and Colitis Foundation of America. Treatment options in IBD. http://www.ccfa.org/info/treatment/ Accessed 23 March 2009.
16 - Panaccione R, Fedorak RN. Primer of current therapies to treat inflammatory bowel disease. In: Satsangi J, Sutherland LR (Eds.), Inflammatory Bowel Diseases (pp335–358). Edinburgh: Churchill Livingstone Elsevier.
17 - Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353(23):2462–76.